Profile
EKSO ISRG BDX BDXA ALC RMD
Company Name Ekso Bionics Holdings, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $9.58M $176.09B $65.60B $64.58B $45.56B $33.16B
Employees 0.07K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Mr. Scott G. Davis Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. - Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM
Ratings
EKSO ISRG BDX BDXA ALC RMD
Quant Rating Score 2 3 3 5 3 3
Quant Rating Sell Neutral Neutral Strong Buy Neutral Neutral
Trading
EKSO ISRG BDX BDXA ALC RMD
Last Close $0.3799 $493.72 $224.92 $59.24 $89.15 $225.79
High 52 $1.49 $610.45 $249.08 $59.24 $100.76 $257.65
Low 52 $0.35 $366.34 $220.02 $59.24 $77.58 $173.83
Price vs. 52 Week High -74.5 % -19.12 % -9.7 % 0 % -11.52 % -12.37 %
Price vs. 52 Week Low 8.54 % 34.77 % 2.23 % 0 % 14.91 % 29.89 %
Total Return
EKSO ISRG BDX BDXA ALC RMD
1 Month Return -31.55 % -16.26 % -0.41 % 0 % 1.12 % -4.57 %
3 Month Return -32.96 % -8.5 % -0.28 % 0 % 5.92 % -5.34 %
6 Month Return -68.34 % -0.06 % -4.49 % 0 % -11.52 % -9.94 %
9 Month Return -65.77 % 15.33 % -3.88 % 0 % -3.37 % 7.07 %
YTD Return -37.72 % -5.41 % -0.86 % 0 % 5.02 % -1.27 %
1 Year Return -73.8 % 26.79 % -5.42 % 0 % 1.16 % 16.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
EKSO ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 1.7 % 1.73 % 0.29 % 0.92 %
Dividend Paid and Capex Coverage Ration (TTM) -266.11 % 2.17 % 1.98 % 1.98 % 2.05 % 3.84 %
Dividend Per Share (TTM) - - 3.89 % 3.89 % 0.26 % 2.07 %
Payout Ratio (TTM) - - 65.26 % 65.26 % 13.01 % 23.76 %
Growth
EKSO ISRG BDX BDXA ALC RMD
Asset Growth -29.3 % 8.54 % 8.54 %
Gross Profit Growth 46.11 % 11.69 % 11.69 %
Revenue Growth 41.57 % 4.16 % 4.16 %
Revenue 3 Year 6.32 % -0.51 % -0.51 %
Revenue 5 Year -52.52 % 8.72 % 8.72 %
Revenue 10 Year -76.1 % 59.37 % 59.37 %
EBIT Growth 2.85 % 13.55 % 13.55 %
Net Income Growth -4.07 % 14.89 % 14.89 %
Net Income 3 Yeari Growth Per Share 53.69 % -18.63 % -18.63 %
Net Income 5 Yeari Growth Per Share 83.43 % 30.19 % 30.19 %
Net Income 10 Yeari Growth Per Share 96.87 % -4.02 % -4.02 %
Operating Income Growth 2.85 % 13.55 % 13.55 %
Operating Cash Flow Growth (CFG) 17.93 % 28.6 % 28.6 %
Operating 3 Year CFG 28.87 % -17.42 % -17.42 %
Operating 5 Year CFG 83.99 % 7.54 % 7.54 %
Operating 10 Year CFG 94.41 % 47.04 % 47.04 %
EPS Growth 2.65 % 18.31 % 18.31 %
EPS Diluted Growth 2.65 % 18.62 % 18.62 %
Book Value Per Share -53.69 % -0.85 % -0.85 %
Share Holder 3 Year Equity Growth Per Share 46.88 % 9.26 % 9.26 %
Share Holder 5 Year Equity Growth Per Share 36.02 % 13.99 % 13.99 %
Share Holder 10 Year Equity Growth Per Share -96.15 % 242.08 % 242.08 %
Dividend Per Share Growth - -2.44 % -2.44 %
Dividend 3 Year Growth Per Share - 4.79 % 4.79 %
Dividend 5 Year Growth Per Share - 4.14 % 4.14 %
Dividend 10 Year Growth Per Share - 74.3 % 74.3 %
Debt Growth -4.49 % 26.65 % 26.65 %
Free Cash Flow Growth 17.95 % 47.47 % 47.47 %
Updated On 31 Dec 2023 30 Sep 2024 30 Sep 2024
Profitability
EKSO ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 53.06 % 67.46 % 45.22 % 45.22 % 55.61 % 57.94 %
Return on Assets TTM -42.51 % 12.39 % 3.16 % 3.16 % 3.35 % 17.49 %
Return on Equity TTM -84.42 % 15.31 % 6.73 % 6.73 % 6.43 % 25.05 %
Return on Capital Employed TTM -54.72 % 13.82 % 5.64 % 5.64 % 5.03 % 24.81 %
Net Income Per EBT TTM 100 % 86.87 % 88.43 % 88.43 % 81.05 % 81.35 %
EBT Per Ebit TTM 108.32 % 113.83 % 73.61 % 73.61 % 88.89 % 98.37 %
EBIT Per Revenue TTM -58.35 % 28.12 % 12.85 % 12.85 % 14.24 % 31.67 %
Cash Flow To Debt Ratio TTM -164.57 % - 19.46 % 19.46 % 36.06 % 175.81 %
Receivables Turnover TTM 2.48 6.16 7.82 7.82 4.77 5.73
Payables Turnover TTM 5.42 14.05 - - 5.7 9.41
Inventory Turnover TTM 1.84 1.83 2.93 2.93 1.94 2.35
Fixed Asset Turnover TTM 757.93 % 179.75 % 312.63 % 312.63 % 205.17 % 734.05 %
Asset Turnover TTM 67.26 % 44.56 % 37.76 % 37.76 % 32.71 % 68.99 %
Operating Cash Flow Per Share TTM -0.49 6.78 12.61 12.61 3.75 10.05
Free Cash Flow Per Share TTM -0.49 3.66 10.14 10.14 2.19 9.45
Cash Per Share TTM 32.21 % 1126.07 % 251.46 % 251.46 % 370.15 % 355.4 %
Operating Cash Flow Sales Ratio TTM -54.93 % 28.91 % 17.68 % 17.68 % 18.66 % 29.96 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.38 % 53.99 % 80.44 % 80.44 % 58.38 % 94.04 %
Cash Flow Coverage Ratios TTM -164.57 % - 19.46 % 19.46 % 36.06 % 175.81 %
Price To Free Cash Flows Ratio TTM -0.97 135.06 22.34 22.04 42.14 23.88
Price To Operating Cash Flows Ratio TTM -0.79 72.86 18.12 17.87 24.59 22.46
Price Cash Flow Ratio TTM -0.79 72.86 18.12 17.87 24.59 22.46
Income Statement (TTM)
EKSO ISRG BDX BDXA ALC RMD
Revenue $0.02B $8.35B $20.18B $20.18B $9.91B $4.69B
Gross Profit $0.01B $5.63B $9.13B $9.13B $5.51B $2.66B
Gross Profit Ratio 53.06% 67.5% 45.22% 45.22% 55.61% 56.67%
EBITDA $-0.01B $2.67B $4.85B $4.85B $2.68B $1.53B
Net Income $-0.01B $2.32B $1.71B $1.71B $1.02B $1.02B
EPS Diluted -0.56 6.42 5.86 5.86 2.05 6.92
Balance Sheet (MRQ)
EKSO ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0.01B $2.21B $31.4B $31.4B $8.79B $2.01B
Total Equity $0.01B $16.53B $25.91B $25.91B $21.55B $4.86B
Total Investments $0B $6.81B $0.45B $0.45B $0.75B $0.17B
Total Debt $0.01B $0B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.03B $18.74B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
EKSO ISRG BDX BDXA ALC RMD
Net Income $-0.01B $2.34B $1.71B $1.71B $1.02B $1.02B
Inventory $0B $-0.83B $0.1B $0.1B $-0.05B $0.17B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.28B
Operating Cash Flow $-0.01B $2.42B $3.84B $3.84B $2.08B $1.4B
Capital Expenditure $0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.62
ALC Alcon Inc. 89.22
ANGO AngioDynamics, Inc. 9.05
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 147.715
ATRC AtriCure, Inc. 33.39
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 38.79
BAX Baxter International Inc. 35.08
BDX Becton, Dickinson and Company 225.97
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 15.405
BLFS BioLife Solutions, Inc. 26.41
COO The Cooper Companies, Inc. 80.51
DXR Daxor Corporation 7.9
FEMY Femasys Inc. 1.49
GCTK GlucoTrack, Inc. 0.3564
ETFs With Exposure to EKSO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 274.99
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 122.025
VXF Vanguard Extended Market Index Fund 0 173.535
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 93.67
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 93.65
DFUS Dimensional U.S. Equity ETF 0.0000235 60.4
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000288 32.85
VTSAX Vanguard Total Stock Market Index Fund 0 133.29
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 131.19
VITSX Vanguard Total Stock Market Index Fund 0 133.31
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 131.2
VEMPX Vanguard Extended Market Index InstlPlus 0 323.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 250.07
Unlock